Is Oscar Health (OSCR) One of the Under-the-Radar AI Stocks to Buy?

Core Viewpoint - Oscar Health Inc. (NYSE:OSCR) is identified as an under-the-radar AI stock with recent upgrades from analysts, indicating a positive outlook despite challenges related to expiring subsidies [1][2][3]. Analyst Upgrades - UBS upgraded Oscar Health from Sell to Neutral, raising the price target from $12 to $17, citing better-than-expected exchange enrollment performance [1]. - Barclays analyst Andrew Mok upgraded Oscar Health from Underweight to Equal Weight, increasing the price target from $13 to $18, anticipating benefits from margin expansion in managed care stocks by 2026 [2]. Market Positioning - Andrew Mok noted that Oscar Health is attractively priced due to the market over-discounting the negative impacts of expiring subsidies, suggesting potential for recovery [3]. - Oscar Health operates as a healthcare technology company in the US, providing health plans to individuals, families, employees, and small group markets [3].